摘要
目的:探讨前列腺素E2对大鼠骨髓间充质干细胞(BMSCs)成骨分化的影响及其机制。方法:将第3代大鼠BMSCs分为3组,空白组用完全培养基培养,前列腺素E2组用含1×10-5 g/L前列腺素E2的培养液培养,前列腺素E2+抑制剂组用p38MAPK阻断剂SB203580处理30 min后用含1×10^-5 g/L前列腺素E2的培养液培养。干预14 d后,Western blot法检测细胞中p38MAPK和磷酸化p38MAPK(p-p38MAPK)蛋白的表达,检测细胞中碱性磷酸酶(ALP)活性,qRT-PCR法检测细胞中ALP、RunX2、骨桥蛋白(OPN)、骨形态发生蛋白2(BMP-2)和核心结合因子α1(Cbfα1)mRNA的表达。结果:与空白组相比,前列腺素E2组细胞中p-p38MAPK/p38MAPK比值、ALP活性,以及ALP、Runx2、OPN、BMP-2、Cbfα1 mRNA的表达水平均升高(P<0.05);与前列腺E2组比较,前列腺素E2+SB203580组细胞中上述各指标降低(P<0.05)。结论:前列腺素E2可通过激活p38MAPK信号通路诱导大鼠BMSCs成骨分化。
Aim:To investigate the effects of prostaglandin E2 on osteogenic differentiation of rat bone marrow mesenchymal stem cells(BMSCs)and its mechanism.Method:The 3rd generation rat BMSCs were divided into 3 groups.BMSCs of the blank group were cultured by complete medium culture,BMSCs of prostaglandin E2 group were cultured by 1×10^-5 g/L prostaglandin E2,and those of prostaglandin E2+SB203580 group were treated by p38MAPK blocker SB203580 for 30 min and then treated by 1×10^-5 g/L prostaglandin E2.After 14 days of intervention,the expressions of p38MAPK and p-p38MAPK proteins were detected by Western blot,the activity of ALP was tested,and the expressions of ALP,OPN,Runx2,BMP-2 and Cbfα1 mRNA were examed by qRT-PCR.Results:Compared with those of the blank group,the ratio of p-p38MAPK/p38MAPK,ALP activity,and the expressions of ALP,Runx2,OPN,BMP-2 and Cbfα1 mRNA in BMSCs of the prostaglandin E2 group were significantly higher(P<0.05),while the indexes mentioned above in the prostaglandin E2+SB203580 group were significantly lower than those in the prostaglandin E2 group(P<0.05).Conclusion:Prostaglandin E2 can induce osteogenic differentiation of rat BMSCs by activating p38MAPK signaling pathway.
作者
才忠民
王欢
尚平
王琦
李劼若
CAI Zhongmin;WANG Huan;SHANG Ping;WANG Qi;LI Jieruo(Department of Spine Surgery,the People′s Hospital of Huadu District,Guangzhou 510800;Sports Medicine Center,the First Affiliated Hospital,Jinan University,Guangzhou 510630)
出处
《郑州大学学报(医学版)》
CAS
北大核心
2020年第1期61-65,共5页
Journal of Zhengzhou University(Medical Sciences)
基金
广东省医学科研基金项目(B2011160)